banda transcan 2 2016ul


The ERA-NET  TRANSCAN-2 (Aligning national/regional translational cancer research programmes and activities) is a collaborative network of ministries, funding agencies and research councils with programmes in translational cancer research.The network is composed of 31 partners from 19 Countries (15 Member States, 3 Associated Countries and a third Country). (go to partners).
Its main objective is the coordination of activities of partners in the translational cancer research funding, avoiding the duplication of efforts and with a more efficient use of available resources.
The project aims at deepening and extending the cooperation among partners through exchange of information, harmonisation of funding mechanisms and assessment of results of the funded research projects,  facilitating the transnational cancer funding in Europe and thus contributing to the building of the European Research Area.
Along this line TRANSCAN-2 launches Joint Transnational Calls for research proposals (JTCs). In the first, co-funded call (JTC 2014) national financial contributions are complemented with an EU contribution (co-fund model). The launch of 4 calls is planned.
The specific challenge is to promote transnational collaborative approach between scientific research teams in demanding areas of translational cancer research, aiming at the integration of basic, clinical and epidemiological research to produce significant results of higher quality and impact, and share data and infrastructures.

Further objectives of the project, structured in 9 Work Packages, are:
•   to monitor the progress of the research projects funded within the first co-funded call as well as the additional planned JTCs, and to analyse the results in order to assess the performance of the funded projects with respect to the call scope
•   to develop and update a strategy for enlarging the network of funding organisation and to promote the participation of all partners in the JTCs
•   to identify scientific priority topics in translational cancer research, through a systematic exchange with the scientific community comprising interactions with relevant projects and stakeholders in the EU and world-wide
•   to establish a communication, dissemination and networking strategy

List of partners

  1. Austrian Science Fund (FWF), Austria

  2. Research Foundation - Flanders (FWO), Belgium, Flanders

  3. Fund for Scientific Research (FNRS), Belgium, French speaking community

  4. Estonian Research Council (ETAg), Estonia

  5. National Cancer Institute (INCa), France

  6. ARC French Foundation for Cancer Research (ARC Foundation), France

  7. Federal Ministry of Education and Research (BMBF), Germany

  8. Project Management Agency in the German Aerospace Centre (PT-DLR), Germany

  9. General Secretariat for Research and Technology, Ministry of Education and Religious Affairs (GSRT), Greece

  10. National Institute of Oncology (OOI), Hungary

  11. The Chief Scientist Office of the Ministry of Health (CSO-MOH), Israel

  12. Ministry of Health (MoH), Italy

  13. Ministry of Education, Universities and Research (MIUR), Italy

  14. National Institute of Health (ISS), Italy

  15. Alliance Against Cancer (ACC), Italy

  16. State Education Development Agency (VIAA), Latvia

  17. Dutch Cancer Society (DCS), The Netherlands

  18. The Netherlands Organisation for Health Research and Development (ZonMw), The Netherlands

  19. The Research Council of Norway (RCN), Norway

  20. Norwegian Cancer Society (NCS), Norway

  21. National Centre for Research and Development (NCBR), Poland

  22. Foundation for Science and Technology (FCT), Portugal

  23. Slovak Academy of Sciences (SAS) , Slovakia

  24. Ministry of Education, Science and Sport (MIZS), Slovenia

  25. National Institute of Health Carlos III (ISCIII), Spain

  26. The Foundation for the support of the Applied Scientific Research and Technology in Asturias (FICYT), Spain

  27. Ministry of Science and Technology (MoST), Taiwan

  28. The Scientific and Technological Research Council of Turkey (TÜBITAK), Turkey

    The following new partners have joined TRANSCAN-2 on 2019:

  29. Regione Toscana (TuscReg) and Toscana Life Sciences (TLS), Italy
  30. Fondazione Regionale per la Ricerca Biomedica (FRRB), Italy
  31. Fundacion Cientifica de la Asociaciòn Espanola Contra el Cancer (FCAECC), Spain
partners logos



 TRANSCAN-3 news:
twitter logoinkedin social media logo
 The new ERA-NET Cofund TRANSCAN-3:
 Sustained collaboration of national and regional programmes in cancer research
is funded by the European Commission under H2020  which started on 1st March 2021 and will last five years (G. A. no. 964264)

A TRANSCAN-2 brochure, highlighting key achievements, is available for download



The TRANSCAN-3 newsletters are published at:

SUBSCRIBE to the newsletters
You can unsubscribe at any moment by clicking on the subscription preferences link at the bottom of a received newsletter

All the TRANSCAN-2 newsletters:

Newsletter 10, Sept.2020
Newsletter 9, Dec.2019

Newsletter 8, May 2019
Newsletter 7, Oct.2018
Newsletter 6, June 2108
Newsletter 5, March 2018
Newsletter 4, Dec. 2017
Newsletter 3, Sept. 2017
Newsletter 2, April 2017
Newsletter 1, Dec. 2016

eu flagship

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643638.

Who's Online

We have 10 guests and no members online